Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA(TM) Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer Following FDA Review
Stock Information for Genprex Inc.
Loading
Please wait while we load your information from QuoteMedia.